FibroGen (MEX:FGEN) Other Long Term Assets : MXN375.7 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is FibroGen Other Long Term Assets?

FibroGen's other long-term assets for the quarter that ended in Dec. 2024 was MXN375.7 Mil.

FibroGen's quarterly other long-term assets increased from Jun. 2024 (MXN86.2 Mil) to Sep. 2024 (MXN86.4 Mil) and increased from Sep. 2024 (MXN86.4 Mil) to Dec. 2024 (MXN375.7 Mil).

FibroGen's annual other long-term assets increased from Dec. 2022 (MXN143.4 Mil) to Dec. 2023 (MXN377.6 Mil) but then declined from Dec. 2023 (MXN377.6 Mil) to Dec. 2024 (MXN375.7 Mil).

FibroGen Other Long Term Assets Historical Data

The historical data trend for FibroGen's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroGen Other Long Term Assets Chart

FibroGen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

68.87

179.54

143.37

377.61

375.74

FibroGen Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial															377.61	83.11	86.16	86.44	375.74

FibroGen Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

FibroGen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (MEX:FGEN) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

FGEN:USA 0IL8:UK 1FG:Germany 1FG:Germany

Address

350 Bay Street, Suite 100, No. 6009, San Francisco, CA, USA, 94158

Website

https://www.fibrogen.com

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.